What question did this study set out to answer?

The research aims to explore patterns of prazosin self-poisoning and assess the implications of its off-label psychiatric use.

July 3, 2026The Medical Journal of Australia0 citations

View Full Paper

Self‐Poisoning With Prazosin and Its Off‐Label Use in Australia, 2014–2024: Analysis of NSW Poisons Information Centre Data

OLOlivia B. E. LalChildren's Hospital at Westmead NBNicholas A. BuckleyThe University of Sydney RCRose CairnsThe University of Sydney

Key Points

The research aims to explore patterns of prazosin self-poisoning and assess the implications of its off-label psychiatric use.
Analysis of 1030 self-poisoning incidents reported to NSW Poisons Information Centre from 2014 to 2024.
Examined trends in self-poisoning cases by year and demographic characteristics.
The number of annual prazosin self-poisonings increased from 13 to 170 over the 11-year period (2014–2024).
Young women were the predominant demographic in these cases, indicating a possible correlation with off-label psychiatric usage.

Abstract

ABSTRACT NSW Poisons Information Centre data identified 1030 deliberate prazosin self‐poisonings over 11 years, rising from 13 to 170 per year (2014–2024). Young women predominated, likely due to expanded off‐label (but accepted) psychiatric use of prazosin. Better evidence on benefits of off‐label use is needed to justify increasing risks.

问 AI

Bookmark

View Full Paper

Cite This Study

Lal et al. (Wed,) studied this question.

synapsesocial.com/papers/6a47518c5c29257aa2578b8f https://doi.org/https://doi.org/10.5694/mja2.70242

问 AI

Bookmark

View Full Paper